In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Zanetti
S
S
Sechi
L A
LA
Molicotti
P
P
Cannas
S
S
Bua
A
A
Deriu
A
A
Carta
A
A
Paglietti
G
G
D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology*; D002417:Cattle; D002460:Cell Line; D024881:Drug Resistance, Bacterial; D006801:Humans; D008264:Macrophages / Q000382:microbiology*; D051379:Mice; D008826:Microbial Sensitivity Tests / Q000379:methods; D009161:Mycobacterium / Q000187:drug effects* / Q000254:growth & development; D009164:Mycobacterium Infections / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000254:growth & development; D011810:Quinoxalines / Q000737:chemistry / Q000494:pharmacology*; D014397:Tuberculosis, Pulmonary / Q000382:microbiology
D000995:Antitubercular Agents; D011810:Quinoxalines; C003282:quindoxin